(Q35277785)

7 August 2017

1 reference

title

The potential impact of the pulmonary microbiome on immunopathogenesis of Aspergillus-related lung disease (English)

1 reference

7 August 2017

0 references

Eva Kolwijck

1

1 reference

7 August 2017

Frank L van de Veerdonk

series ordinal

2

1 reference

7 August 2017

language of work or name

English

0 references

publication date

27 October 2014

1 reference

European Journal of Immunology

7 August 2017

published in

1 reference

7 August 2017

volume

44

1 reference

7 August 2017

issue

11

1 reference

7 August 2017

page(s)

3156-3165

1 reference

Selective protection against conidia by mononuclear and against mycelia by polymorphonuclear phagocytes in resistance to Aspergillus. Observations on these two lines of defense in vivo and in vitro with human and mouse phagocytes

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344404

Invasive aspergillosis in the ICU: an emerging disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344404

Invasive pulmonary aspergillosis is a frequent complication of critically ill H1N1 patients: a retrospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344404

Pathogenesis of allergic bronchopulmonary aspergillosis in cystic fibrosis: current understanding and future directions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344404

The microbiome of the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344404

The airway microbiome and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344404

Chapter 12: Human microbiome analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344404

Analysis of the lung microbiome in the "healthy" smoker and in COPD

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344404

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344404

Factors associated with mortality in transplant patients with invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344404

Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344404

Early NK cell-derived IFN-{gamma} is essential to host defense in neutropenic invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344404

Underlying conditions in chronic pulmonary aspergillosis including simple aspergilloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344404

Comparison of serum markers for allergic bronchopulmonary aspergillosis in cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344404

Chemokines in allergic aspergillosis--from animal models to human lung diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344404

Immunological mechanisms behind the cystic fibrosis-ABPA link

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344404

Innate immunity and intestinal microbiota in the development of Type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344404

Stimulation of TLR2 and TLR4 differentially skews the balance of T cells in a mouse model of arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344404

Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344404

The emerging world of the fungal microbiome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344404

Interactions between commensal fungi and the C-type lectin receptor Dectin-1 influence colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344404

The macrophage mannose receptor induces IL-17 in response to Candida albicans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344404

Interleukin-17-producing T helper cells in autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344404

Exposure to Candida albicans polarizes a T-cell driven arthritis model towards Th17 responses, resulting in a more destructive arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344404

The Candida Th17 response is dependent on mannan- and beta-glucan-induced prostaglandin E2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344404

Gut dysbiosis promotes M2 macrophage polarization and allergic airway inflammation via fungi-induced PGE₂.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344404

Characterization of the oral fungal microbiome (mycobiome) in healthy individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344404

Interindividual variability and intraindividual stability of oral fungal microbiota over time.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344404

Lung-enriched organisms and aberrant bacterial and fungal respiratory microbiota after lung transplant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344404

Aspergillus fumigatus-induced IL-22 is not restricted to a specific Th cell subset and is dependent on complement receptor 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344404

IL-22 increases the innate immunity of tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344404

The cytokine IL-22 promotes pathogen colonization by suppressing related commensal bacteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344404

Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: an emerging fungal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344404

Clinical features of invasive pulmonary aspergillosis vs. colonization in COPD patients distributed by gold stage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344404

The lung tissue microbiome in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344404

The lung microbiome in moderate and severe chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344404

Prognostic factors, clinical course, and hospital outcome of patients with chronic obstructive pulmonary disease admitted to an intensive care unit for acute respiratory failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344404

Repeated Aspergillus isolation in respiratory samples from non-immunocompromised patients not selected based on clinical diagnoses: colonisation or infection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344404

Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344404

Importance of Aspergillus spp. isolation in Acute exacerbations of severe COPD: prevalence, factors and follow-up: the FUNGI-COPD study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344404

Chronic obstructive pulmonary disease and the risk for ventilator-associated pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344404

Pandemic 2009 influenza A(H1N1) virus infection coinciding with invasive pulmonary aspergillosis in neutropenic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344404

Influenza A (H1N1) complicated by invasive aspergillosis in non-severely immunocompromised patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344404

Invasive aspergillosis after pandemic (H1N1) 2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344404

Modulation of potential respiratory pathogens by pH1N1 viral infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344404

Viruses and microbiome alterations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344404

Role of antibiotics and fungal microbiota in driving pulmonary allergic responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344404

Differences in fungi present in induced sputum samples from asthma patients and non-atopic controls: a community based case control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344404

The changing microbial epidemiology in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344404

Microbiota abnormalities in inflammatory airway diseases - Potential for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344404

Lung infections in cystic fibrosis: deriving clinical insight from microbial complexity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344404

The effect of chronic infection with Aspergillus fumigatus on lung function and hospitalization in patients with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344404

Pseudomonas aeruginosa and their small diffusible extracellular molecules inhibit Aspergillus fumigatus biofilm formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344404

Intravenous antibiotics reduce the presence of Aspergillus in adult cystic fibrosis sputum

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344404

Immune response, diagnosis and treatment of allergic bronchopulmonary aspergillosis in cystic fibrosis lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344404

Microbial exposure during early life has persistent effects on natural killer T cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344404

Induction of colonic regulatory T cells by indigenous Clostridium species

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344404

Induction of intestinal Th17 cells by segmented filamentous bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344404

Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344404

Requisite role for the dectin-1 beta-glucan receptor in pulmonary defense against Aspergillus fumigatus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344404

Neutrophils produce interleukin 17A (IL-17A) in a dectin-1- and IL-23-dependent manner during invasive fungal infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344404

Th17 cells in the setting of Aspergillus infection and pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344404

Dysregulation in lung immunity - the protective and pathologic Th17 response in infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344404

Microbiota regulates immune defense against respiratory tract influenza A virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344404

Commensal bacteria calibrate the activation threshold of innate antiviral immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344404

Priming of natural killer cells by nonmucosal mononuclear phagocytes requires instructive signals from commensal microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344404

A nonredundant role for plasmacytoid dendritic cells in host defense against the human fungal pathogen Aspergillus fumigatus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344404

Essential role for neutrophils but not alveolar macrophages at early time points following Aspergillus fumigatus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344404

Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344404

The β-glucan receptor dectin-1 promotes lung immunopathology during fungal allergy via IL-22.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344404

Innate lymphoid cells and asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344404

Innate lymphoid cell interactions with microbiota: implications for intestinal health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344404

Commensal bacteria-derived signals regulate basophil hematopoiesis and allergic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344404

Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344404

Asthma Prevention by Lactobacillus Rhamnosus in a Mouse Model is Associated With CD4(+)CD25(+)Foxp3(+) T Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344404

Regulation of Cytokine Secretion in Human CD127+ LTi-like Innate Lymphoid Cells by Toll-like Receptor 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344404

IL-23 and the Th17 pathway promote inflammation and impair antifungal immune resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344404

Prevalence and antimicrobial susceptibility of microorganisms isolated from sputa of patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344404

7 January 2021

The new microbiology of cystic fibrosis: it takes a community

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344404

7 January 2021

Pattern recognition receptors and their role in invasive aspergillosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344404

7 January 2021

Airway hyperresponsiveness, but not airway remodeling, is attenuated during chronic pulmonary allergic responses to Aspergillus in CCR4-/- mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344404

7 January 2021

Lactobacillus reuteri-induced regulatory T cells protect against an allergic airway response in mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344404

7 January 2021

Immunomodulatory effects of feeding with Bifidobacterium longum on allergen-induced lung inflammation in the mouse

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344404

7 January 2021

Identifiers

DOI

10.1002/EJI.201344404

1 reference

7 August 2017

1 reference